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Case Report
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The presence of myositis specific antibodies
allows classification of polymyositis into
clinically important subsets. Anti Jo-I
autoantibodies are associated with 'mechanic's
hands' and interstitial lung disease.
We report three patients who presented with
painful weak muscles, a violaccous rash on the
extensor aspect of their hands, elevated muscle
enzymes, electromyographic and muscle biopsy
findingstypicalofpolymyositis. Allthreepatients
had anti Jo-I autoantibodies, 'mechanic's hands'
and evidence of interstitial lung disease on CT
scan. An incomplete response to corticosteroids
was observed in all three patients and additional
immunosuppression was required.
CASE REPORT 1
A 41-year -old unemployed man was referred by
his general practitioner to a general physician.
He presented with shoulder muscle stiffness and
weakness. On questioning he was found to have
breathlessness onwalkingtwohundredyards. He
also described symptoms of Raynaud's
phenomenon. On clinical examination he had a
heliotrope skin rash over the extensor aspect of
his metacarpal-phalangeal and interphalangeal
joints. Fissuring and cracks were noted on the
distaldigital skinpads onhis thumbs andfingers.
A proximal muscle weakness of grade 4/5, was
notedinhisupperlimbs. Respiratoryexamination
was reported as unremarkable and without signs
of cardiac insufficiency.
Serum creatine kinase was elevated at 1467 IU/L
(normal range 0-180 IU/L). Subsequent
electromyography and histological findings on
muscle biopsy showed typical features of
inflammatory myopathy. The patient was
commenced on 40mg of prednisolone. An
incomplete response was noted in terms of
symptoms and muscle enzymes (creatine kinase
ranged from 539-928 IU/L).
The patient was subsequently referred to a
consultant rheumatologist where anti Jo-I
autoantibodytestingwasfoundtobepositive and
CT scanofchestrevealedpredominantly midand
lowerzoneinterstitialpatternmarkingswithsome
'ground glass' appearances. On pulmonary
functiontesting,transferfactorperlitreofalveolar
volume (KI.CO) was found to be 1.58 m mol min-'
kpa'I (94% predicted). Azathioprine was
commenced in addition to corticosteroids.
CASE REPORT 2
A 40-year-old housewife was referred by her
general practitioner with a gradual onset ofneck,
shoulder and thigh pains. She noticed while
playing badminton that her serve 'wasn't as
strong'. Overthisperiodoftimeshealsodescribed
breathlessness. On examination, she had a
heliotrope rash over the extensor aspect of her
metacarpal-phalangeal/inter-phalangeal joints
and 'mechanic's hands' (Figure 1). She had mild
proximal muscle weakness, graded 4+/5 in her
shoulder and pelvic girdles. Fine bibasal early
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inspiratory crepitations were heard on
auscultation.
Serum creatine kinase was 1518 IU/L (normal
range0-180IU/L). AntiJo-I autoantibodytesting
was positive. Subsequently an electromyogram
revealed mild myopathic changes and muscle
biopsy revealed features in keeping with
inflammatorymyopathy. Earlyinterstitialfibrosis
was seen on CT scan of chest. K1.CO was
measured at 2.01 m mol min-' kpa'I (113% of
predicted).
This patient was commenced on 40mg of
prednisolone daily. A moderate symptomatic
improvementwasobservedbutherserummuscle
enzymes remained elevated. The addition of
azathioprine coincided with a symptomatic
improvement and normalisation of muscle
strengthandenzymes. Hercorticosteroidtherapy
was slowly reduced to 7.5mg of prednisolone
daily, without relapse.
Fig 1. 'Mechanic's hands' - characterized by scaling
and hyperkeratosis of the distal skin pad and
lateral aspect of the fingers.
CASE REPORT 3
A 30-year-old school teacher was referredby his
generalpractitioner. Hereported an acutehistory
ofpainful shoulders and 'roughening' ofthe skin
at his fingertips. During this period he noted
himself to be 'breathless' on exertion. On
examination fissuring and cracking of the skin
pads in his distal fingers, typical of 'mechanic's
hands' was observed. Atypical dermatomyositis
rash was present on the extensor aspect of his
hands. Muscle weakness was not observed. Fine
bibasal early inspiratory crepitations were heard
on auscultation of his chest.
Fig 2. CT scan of chest revealing bibasal interstitial
changes in apatientwith antiJo-I autoantibodies.
Initial serum creatine kinase was mildly elevated
at 296 IU/L. Other muscle enzymes were mildly
elevated AST 51 IU/L (normal range 10-42 IU/
L) and Aldolase 8.2 U/L (Normal range 0.5-3.12
U/L). Anti Jo-I antibody testing was positive,
confirmingtheclinicalsuspicionofantisynthetase
syndrome. Mild myopathic changes were noted
on his electromyogram. CT scan of his chest
revealed bibasal interstitial changes (figure 2).
K1.CO was 1.3 m mol minm' kpa-' (76% of
predicted). An incomplete response to 40-60mg
of prednisolone was observed. A clinical
improvementwasnotedintermsofbreathlessness
and muscle enzymes with the addition of
azathioprone. His corticosteroid therapy was
reduced to 5mg of prednisolone daily, without
relapse.
DISCUSSION
These cases illustrate that the presence of
'mechanic's hands' and serum antibodies to anti
Jo-i, should alert physicians to the possible
presence of interstitial lung disease.
The annual incidence of polymyositis/
dermatomyositis has been estimated at 6 cases
permillionperyear, withpeakage ofonset at45-
55 years.' Bohan and Peter's classification2 of
patients with idiopathic inflammatory
myopathies, defined subgroups with specific
clinical and pathological criteria, More recently,
the detection ofmyositis specific autoantibodies,
has been found to aid classification of defined
subgroups with regard to clinical features,
response to treatment and prognosis.3
Antisynthetase autoantibodies are the most
commonmyositis-specific autoantibody. AntiJo-I
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accounts for three-quarters ofthe antisynthetase
family. Anti Jo-I autoantibodies are found in 20-
30% of patients with idiopathic inflammatory
myositis. Love et al observed particular clinical
features, rapidity of onset and response to
treatment in patients with antisynthetase
autoantibodies (Table).'
TABLE
Diseaseprofile ofpatients with antisynthetase
autoantibodies
Sex ratio - Female/Male 1.7
Age at diagnosis 4th decade
Onset Acute
Major clinical features Interstitial lung disease
Fever
Raynauds phenomenon
'mechanic's hands'
Steroid response Moderate
Mortality (%) 20
Anti Jo-I myositis usually has an acute onset in
the spring. Patients with antisynthetase
autoantibodies, compared to patients without
these autoantibodies, have significantly more
frequent distinctive clinical features -
'Mechanic's hands', non-erosive arthritis, fever,
Raynaud's and interstitial lung disease. As
illustrated in fig. 1, 'Mechanics hands' is
characterised by scaling, fissuring and
hyperkeratosis of the distal skin pad and lateral
aspect of the fingers. 'Mechanic's hands' are
present in approx. 70% of patients with
antisynthetase autoantibodies.
Interstitial lung disease has been reported in
approximately90%ofpatientswithantisynthetasc
autoantibodies I and is an important cause of
mortality. Asymptomatic patients may have
radiographic manifestation of interstitial lung
disease and breathlessness may be due to non-
pulmonary problems. Respiratory muscle
weakness, cardiac disease and aspiration
pneumonia may also cause breathlessness in
patients with inflammatory muscle disease.9' 10,11
However, the presence of 'mechanic's hands'
and anti Jo-I autoantibodies suggests that
interstitial lung disease is the likely cause of
breathlessness on exertion. Sauty et al reported
four cases of patients who presented with
interstitial lung disease without muscle
involvement and whose serum was positive for
anti Jo-i autoantibodies.4
Patients with antisynthetase syndrome tend to
haveamoderateresponsetocorticosterolds. Sixty
percent of patients will experience a flare-up of
their myositis during tapering of corticosteroid
therapy.3 Late relapses after initial remission
appear to be more frequent in patients with
antisynthetase syndrome.' Therefore
corticosteroid therapy should be tapered slowly,
andclose surveillanceisnecessarytomonitorfor
disease exacerbation. Because of the poor
response to corticosterolds, immunosuppressive
agents should be considered early in patients
with antisynthetase syndrome. This may have
benefits in terms ofreducing steroid side-effects
and possibly improved response.6 A report by
Joffe et al suggests that patients with
antisynthetase autoantibodies may respond more
favourablytomethotrexate thantoazathioprine.7
Although there is no evidence that methotrexate
pulmonary toxicity is more common in patients
with interstitial lung disease, the development of
this complication in a myositis patient with
interstitial lung disease, may increase the risk of
respiratory failure and present with diagnostic
difficulties. Thus, as illustrated in these three
cases, azathioprine was the preferred
immunosuppressant. Deteriorating Ki.CO in
patients with interstitial and antisynthetase
autoantibodies mayrespondtomoderatedosesof
cyclosporine and azathioprine in addition to low
dose corticosteroid.4 In other reports
cyclophosphamide in association with
corticosteroidshasshownaclinicalandfunctional
response.8
Patients with antisynthetase syndrome have a
highermortality rate (21%) thanmyositis overall
(7%),3 which is probably related to interstitial
lung disease.
Thephysical sign of 'mechanics hand' is auseful
sign for identifying patients with anti Jo-I
myositis. ThepresenceofantiJo-I autoantibodies
is particularly important because it alerts the
clinician to interstitial lung disease and the fact
that additional immunosuppression may be
required.
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